Nasdaq · CIK 0000926282
ADTN ADTRAN Holdings, Inc.
F
15 / 100
Material weaknesses
3
Restatements
1
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
0
Deductions
85
Remediation credit
0
Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.
Disclosures, in the company's words
“The material weaknesses resulted in the restatements and revision to our consolidated financial statements for the years ended December 31, 2022, 2023 and 2024, as well as the condensed consolidated financial statements for the quarterly and year-to-date periods ended September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024, June 30, 2024 and September 30, 2024.”
“Adtran did not design and maintain effective controls over financial statement preparation, presentation and disclosure commensurate with its financial reporting requirements. Specifically, Adtran did not design and maintain effective controls over the presentation and disclosure of transactions, including non-controlling interest.”
“Adtran did not design and maintain effective controls in response to the risks of material misstatement. Specifically, changes to existing controls or the implementation of new controls have not been sufficient to respond to changes to the risks of material misstatement to financial reporting.”
“Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that due to the material weaknesses in our internal control over financial reporting described below, our disclosure controls and procedures were not effective as of September 30, 2026.”
“The Company has taken certain remedial actions to address the material weaknesses in its internal controls associated with these findings.”
“we identified errors in our previously issued financial statements related to the historical accounting for certain inventory and cost of revenue transactions ("Adjustment"). The affected periods included the annual periods ended December 31, 2023 and 2024 and the interim periods ended March 31, 2024, June 30, 2024 and September 30, 2024.”
“We have had to restate our previously issued consolidated financial statements and, as part of that process, have identified material weaknesses in our internal control over financial reporting.”
“We have had to restate our previously issued consolidated financial statements and, as part of that process, have identified material weaknesses in our internal control over financial reporting.”
Filings read
- 10-Q · 2026-11-05read
- 10-Q · 2026-08-04queued
- 10-Q · 2026-05-05queued
- 10-K · 2026-02-26queued
- 10-Q · 2025-11-04queued
- 8-K · 2025-09-22queued
- 8-K · 2025-09-17queued
- 10-Q · 2025-08-05queued
- 10-K/A · 2025-05-20queued
- 10-Q · 2025-05-20queued
- 8-K · 2025-05-13queued
- NT 10-Q · 2025-05-13queued
- 10-K · 2025-03-03queued
- 10-Q · 2024-11-12queued
Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.